WO2005007234A2 - Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals - Google Patents

Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals Download PDF

Info

Publication number
WO2005007234A2
WO2005007234A2 PCT/US2004/022120 US2004022120W WO2005007234A2 WO 2005007234 A2 WO2005007234 A2 WO 2005007234A2 US 2004022120 W US2004022120 W US 2004022120W WO 2005007234 A2 WO2005007234 A2 WO 2005007234A2
Authority
WO
WIPO (PCT)
Prior art keywords
waveforms
treatment member
endocrine
exocrine
glands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/022120
Other languages
French (fr)
Other versions
WO2005007234A3 (en
Inventor
Eleanor Schuler
Claude K. Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Medicus Inc
Original Assignee
Science Medicus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Medicus Inc filed Critical Science Medicus Inc
Priority to MXPA06000239A priority Critical patent/MXPA06000239A/en
Priority to AU2004257711A priority patent/AU2004257711A1/en
Priority to EP04777910A priority patent/EP1651307A2/en
Priority to JP2006518940A priority patent/JP2007528751A/en
Priority to CA002531679A priority patent/CA2531679A1/en
Publication of WO2005007234A2 publication Critical patent/WO2005007234A2/en
Publication of WO2005007234A3 publication Critical patent/WO2005007234A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters
    • A61N1/36139—Control systems using physiological parameters with automatic adjustment

Definitions

  • the process includes, but is not limited to, glandular participation in the regulation of body temperature, heart rate, respiration, digestion, energy metabolism, immunity and reproduction. Glandular secretions also are used to protect the human or animal body from invading microbes, environmental dust and other wind carried or propelled chemicals, smoke products or odors.
  • the glandular flow of chemicals or hormones plays an important role in the homeostasis process.
  • secretory glands There are two principal classes of secretory glands. There are the “endocrine” glands that secrete directly into the blood stream also there are the “exocrine” glands that produces a secretion onto the surface of the body and to protect with secretions in the exterior orifices or into the interior of organs other than directly into the bloodstream.
  • the ability to electrically cause the endocrine or exocrine glands to secrete or to cease secreting or even to partially secrete would be a compelling medical technology for potentially controlling or adjusting body homeostasis.
  • the control of the glands is by means of neuro-electrical coded signals that originate in the brain and brain stem.
  • Puberty is evolved in male and female mammals because of the long-term influence of endocrine glands.
  • Such system of glands is controlled by actual neuro-electrical coded signals (waveform) generated by a device that records, stores and rebroadcast it would greatly add to the clinical medicine tools.
  • Such glandular control technology would provide a clinical neuro-electric method to fine-tune the function of many glandular based biological systems for the benefit of mankind.
  • the invention would use the actual neuro-electrical coded signals that send operational information to operate and regulate the wide variety of endocrine and exocrine glands of the human and animal body. Theses actual neuron signals travel along selected nerves to send the operational commands to the target gland.
  • the glands of the human and other mammals are operated by neuro-electrical coded signals from the brain which, in turn can excrete, in selected cases, chemical instructional signals.
  • the exocrine glands do not excrete into the blood stream as do the endocrine glands. These types of glands have a type of duct system to flow the secretions outward.
  • the Exocrine glands excrete or secrete largely onto surfaces exterior to the body such as the sweat glands which help cool the body as a contribution to body homeostasis.
  • the sebaceous glands lubricate the surface of the skin with an oily substance.
  • the lacrimal glands make tears to cleanse and lubricate the eyes.
  • Important exocrine glands are the mammary glands, which provide babies milk.
  • exocrine glands are those that provide digestive chemicals such as saliva and digestive juices that affect the mouth, stomach and intestines to begin as the first step to accomplish the digestion of food.
  • digestive chemicals such as saliva and digestive juices that affect the mouth, stomach and intestines to begin as the first step to accomplish the digestion of food.
  • wax producing glands in the external ear canal for protection from insects and microbes.
  • An example of an exocrine gland in a non-mammal species is the poison gland in snakes which is injected via fangs into a victim, which is usually a mammal, as an aid in catching food and to begin the digestive process. This is a representative sampling of the endocrine glands which can be regulated by neuro-electrical coded signals.
  • Endocrine glands include the pituitary, thyroid, adrenal, parathyroid, ovary, testis and part of the pancreas. There is also the placenta, thymus and pineal gland.
  • the prostate may be considered an exocrine gland.
  • the lubricating vaginal canal mucous produced by the adult female in response to sexual stimulation can be considered an exocrine gland.
  • the protective mucus produced in the bronchial tubes of the respiratory tract also qualifies as exocrine type.
  • the kidney is also an excretory gland plus a vital organ. It produces hormones involved in the control of blood pressure and for erythropoiesis which is the production of red blood cells.
  • the Kidney also functions as a vital organ filter to remove soluble waste products from the blood stream. Therefore the kidney is part a method to remove certain liquid waste and it is an endocrine gland too.
  • the endocrine and exocrine glandular operating signal(s) occur naturally as a burst or continuous pattern of signals followed by a pause and then another burst of neuron activity followed by a pause of short or long duration and so it is on and on throughout life.
  • Endocrine and exocrine glandular activity requires variable repetitive neuro-electrical coded signals as humans or animals live.
  • Various glandular secretions operate in a symphonic pattern being conducted by the brain to accomplish the mission assigned, all aimed at maintaining the best body homeostasis.
  • Summary of the Invention The invention provides a method for controlling endocrine and exocrine glands.
  • Stored neuro-electrical coded signals that are generated and carried in the body are selected from a storage area.
  • the selected waveforms are then transmitted to a treatment member which is in direct contact with the body.
  • the treatment member then broadcasts the selected neuro-electrical coded signals to a muscle in the body.
  • the neuro-electrical coded signals may be selected from a storage area in a computer, such as a scientific computer.
  • the process of transmitting the selected neuro-electrical coded signals can either be done remotely or with the treatment member connected to a control module.
  • the transmission may be seismic, electronic, or via any other suitable method.
  • the invention fiirther provides an apparatus for controlling endocrine and exocrine glands.
  • the apparatus includes a source of collected neuro-electrical coded signals that are indicative of endocrine and exocrine glands ft ctioning, a treatment member in direct contact with the body, means for transmitting collected waveforms to the treatment member, and means for broadcasting the collected neuro-electrical coded signals from the treatment member to the endocrine and exocrine glands.
  • the transmitting means may include a digital to analog converter.
  • the source of collected waveforms preferably comprises a computer which has the collected waveforms stored in digital format.
  • the computer may include separate storage areas for collected neuro-electrical coded signals of different categories.
  • the treatment member may be comprised of an antenna or an electrode, or any other means of broadcasting one or more neuro-electrical coded signals directly to the body.
  • FIG. 1 is a schematic diagram of one form of apparatus for practicing the method according to the invention
  • FIG 2 is a schematic diagram of another form of apparatus for practicing the method according to the invention
  • FIG. 3 is a flow chart of the method according to the invention.
  • Skin usually has a 1000 to 30,000 ohm resistance while the interior of the body is quite conductive. All coded signals operate at less than 1 volt, naturally. Applied voltage may be up to 20 volts according to the invention to allow for voltage loss during the transmission or conduction of the required coded signals through mylin nerve sheath or resistive fat and other material. Current should always be less than 2 amps output for the invention.
  • Direct conduction into the nerves via electrodes connected directly to such nerves will likely have outputs of less than 3 volts and current of less than one-tenth of an amp.
  • Up to 10 or more channels may be used simultaneously to exert medical treatment on glandular control to aid a patient in moving or performing muscular tasks suitable to his or her well-being as medical treatment.
  • the invention encompasses both a device and a method for endocrine and exocrine gland control by means of neuro-electrical coded signals.
  • One form of a device 10 for endocrine and exocrine gland control, as shown in Fig. 1, is comprised of at least one treatment member 12, and a control module 14.
  • the treatment member 12 is in direct contact with a body and receives a neuro-electrical coded signal from the control module 14.
  • the treatment member 12 may be an electrode, antenna, a seismic transducer, or any other suitable form of conduction attachment for broadcasting endocrine and exocrine gland signals that regulate or operate glandular function in human or animals.
  • the treatment member 12 may be attached to efferent nerves leading to the endocrine and exocrine glands, afferent nerves leading to the brain or brainstem to accomplish modulation of glandular output, the cervical spine, the neck, or the endocrine and exocrine glands in a surgical process. Such surgery may be accomplished with "key-hole" entrance in a thoracic or limb stereo-scope procedure. If necessary a more expansive thoracotomy approach may be required for more proper placement of the treatment member 12.
  • the control module 14 is comprised of at least one control 16, and an antenna 18.
  • the control 16 allows the device to regulate the signal transmission into the body.
  • the control module 14 and treatment member 12 can be entirely separate elements allowing the device 10 to be operated remotely.
  • the control module 14 can be unique, or can be any appropriate conventional device which can provide neuro-electrical coded signals for transmission to the treatment member 12.
  • the control module 14' and treatment member 12' are connected. Similar members retain the same reference numerals in this figure. Additionally, Fig.
  • FIG. 2 further shows another embodiment of the device 10' as being connected to a computer 20, which provides greater capacity to store the neuro-electrical coded signals.
  • the output voltage and amperage provided by the device 10' during treatment shall not exceed 20 volts or 2 amps for each signal.
  • the computer 20 is used to store the unique neuro-electrical coded signals, which are complex and unique to the endocrine and exocrine glands. It is a neuro-electrical coded signal(s) selected from the stored library of neuro-electrical coded signals (waveforms) in the computer 20 which is transmitted to the control module 14' and used for treatment of a patient.
  • the waveform signals, and their creation, are described in greater detail in U.S. Patent Application Serial No.
  • the invention further includes a method, as shown in Fig. 3 , for using the device 10, 10 ' for endocrine and exocrine gland control.
  • the method begins at step 22 by selecting one or more stored neuro-electrical coded signals from a menu of cataloged neuro-electrical coded signals.
  • the neuro-electrical coded signals selected activate, deactivate, secrete, or adjust the endocrine and exocrine glands.
  • Such neuro-electrical coded signals are similar to those naturally produced by the brain structures for balancing and controlling glandular processes.
  • the neuro-electrical coded signals may be adjusted, in step 24, to perform a particular function in the body. Alternatively, if it is decided that the neuro-electrical coded signals do not need to be adjusted, step 24 is skipped and the process proceeds directly with step 26.
  • the neuro-electrical coded -signal is transmitted to the treatment member 12, 12' ofthe device 10, 10'.
  • the treatment member 12, 12' broadcasts the neuro-electrical coded signals to the endocrine and exocrine glands or nerve location, as shown in step 28.
  • the device 10, 10' utilizes appropriate neuro-electrical coded signals to adjust or modulate glandular action via conduction or broadcast of neuro-electrical coded signals into selected nerves.
  • Controlling endocrine and exocrine gland function may require sending neuro-electrical coded signals into one or more nerves, including up to ten nerves simultaneously. It is believed that target glands can only "respond" to their own individual neuro-electrical coded signal.
  • the process of broadcasting by the treatment member 12, 12' is accomplished by direct conduction or transmission through unbroken skin in a selected appropriate zone on the neck, head, limb(s), spine, or thorax, or abdomen. Such zone will approximate a position close to the nerve or nerve plexus onto which the signal is to be imposed.
  • the treatment member 12, 12' is brought into contact with the skin in a selected target area that allows for the transport of the signal to the target nerve(s).
  • the process of broadcasting the neuro-electrical coded signal is accomplished by direct conduction via attachment of an electrode to the receiving nerve or nerve plexus. This requires a surgical intervention as required to physically attach the electrode to the selected target nerve.
  • Direct implantation on the nervous system of the selected endocrine and exocrine glands may be performed in order to transmit signals to control all or some glandular function. Such implantation can be presynaptic or post synaptic and may be attached to ganglion or nerve plexus associated with the desired secretion function.
  • the process of broadcasting is accomplished by transposing the neuro-electrical coded signal into a seismic form where it is sent into a region of the head, neck, limb(s), spine, or thorax in a manner that allows the appropriate "nerve” to receive and to obey the coded instructions of such seismic signal.
  • the treatment member 12, 12' is pressed against the unbroken skin surface using an electrode conductive gel or paste medium to aid conductivity.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Electrotherapy Devices (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

A method and device for endocrine and exocrine gland control. The method comprises selecting neuro-electrical coded signals from a storage area that are representative of body organ function. The selected neuro-electrical coded signals are then transmitted to a treatment member, which is in direct contact with the body, and which then broadcasts the neuro-electrical coded signals to a specific endocrine and exocrine gland nerve or gland to modulate the gland functioning. A control module is provided for transmission to the treatment member. The control module contains the neuro-electrical coded signals which are selected and transmitted to the treatment member, and computer storage can be provided for greater storage capacity and manipulation of the neuro-electrical coded signals.

Description

REGULATION OF ENDOCRINE AND EXOCRINE GLANDS BY MEANS OF NEURO-ELECTRICAL CODED SIGNALS Related Applications This is the non-provisional filing of application Serial No. 60/486,089, filed July 10, 2004, entitled "Regulation of Endocrine and Exocrine Glands By Means of Neuro-Coded Signals." Background of the Invention This invention relates to a device and method for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals. Bodily homeostasis is the regulation of the milieu interieur (internal environment) of the living mammalian body. Homeostasis is the process through which organs, glands and the central and peripheral nervous system harmoniously function to balance life equilibrium. The process includes, but is not limited to, glandular participation in the regulation of body temperature, heart rate, respiration, digestion, energy metabolism, immunity and reproduction. Glandular secretions also are used to protect the human or animal body from invading microbes, environmental dust and other wind carried or propelled chemicals, smoke products or odors. The glandular flow of chemicals or hormones plays an important role in the homeostasis process. There are two principal classes of secretory glands. There are the "endocrine" glands that secrete directly into the blood stream also there are the "exocrine" glands that produces a secretion onto the surface of the body and to protect with secretions in the exterior orifices or into the interior of organs other than directly into the bloodstream. The ability to electrically cause the endocrine or exocrine glands to secrete or to cease secreting or even to partially secrete would be a compelling medical technology for potentially controlling or adjusting body homeostasis. The control of the glands is by means of neuro-electrical coded signals that originate in the brain and brain stem. The ability to influence the amount of chemicals, hormones or aqueous/mucoid substances to influence the body's response to stress, sexual function, lactation, tears, digestive juices, salt & water balance and behavior. Puberty is evolved in male and female mammals because of the long-term influence of endocrine glands. If such system of glands is controlled by actual neuro-electrical coded signals (waveform) generated by a device that records, stores and rebroadcast it would greatly add to the clinical medicine tools. Such glandular control technology would provide a clinical neuro-electric method to fine-tune the function of many glandular based biological systems for the benefit of mankind. The invention would use the actual neuro-electrical coded signals that send operational information to operate and regulate the wide variety of endocrine and exocrine glands of the human and animal body. Theses actual neuron signals travel along selected nerves to send the operational commands to the target gland. The glands of the human and other mammals are operated by neuro-electrical coded signals from the brain which, in turn can excrete, in selected cases, chemical instructional signals. These chemical signals are transferred to target organs via the blood stream in the case of the endocrine glands. The exocrine glands do not excrete into the blood stream as do the endocrine glands. These types of glands have a type of duct system to flow the secretions outward. The Exocrine glands excrete or secrete largely onto surfaces exterior to the body such as the sweat glands which help cool the body as a contribution to body homeostasis. The sebaceous glands lubricate the surface of the skin with an oily substance. The lacrimal glands make tears to cleanse and lubricate the eyes. Important exocrine glands are the mammary glands, which provide babies milk. The class of species called "mammals" gets their name because they nurse their young from mammary glands. Another type of exocrine glands are those that provide digestive chemicals such as saliva and digestive juices that affect the mouth, stomach and intestines to begin as the first step to accomplish the digestion of food. There are wax producing glands in the external ear canal for protection from insects and microbes. An example of an exocrine gland in a non-mammal species is the poison gland in snakes which is injected via fangs into a victim, which is usually a mammal, as an aid in catching food and to begin the digestive process. This is a representative sampling of the endocrine glands which can be regulated by neuro-electrical coded signals. These glands are ductless and transfer their secretory hormone products directly into the blood stream. The blood stream carries the endocrine hormones to distant cells or target organs within the body to control short or long-term functions. The following list is not meant to be complete or all encompassing, but to provide a picture of the arena in which the invention operates. Endocrine glands include the pituitary, thyroid, adrenal, parathyroid, ovary, testis and part of the pancreas. There is also the placenta, thymus and pineal gland. The prostate may be considered an exocrine gland. The lubricating vaginal canal mucous produced by the adult female in response to sexual stimulation can be considered an exocrine gland. The protective mucus produced in the bronchial tubes of the respiratory tract also qualifies as exocrine type. The kidney is also an excretory gland plus a vital organ. It produces hormones involved in the control of blood pressure and for erythropoiesis which is the production of red blood cells. The Kidney also functions as a vital organ filter to remove soluble waste products from the blood stream. Therefore the kidney is part a method to remove certain liquid waste and it is an endocrine gland too. The endocrine and exocrine glandular operating signal(s) occur naturally as a burst or continuous pattern of signals followed by a pause and then another burst of neuron activity followed by a pause of short or long duration and so it is on and on throughout life. Such signal(s) amplitude or time of pause can be varied to accomplish the glandular activity required. Endocrine and exocrine glandular activity requires variable repetitive neuro-electrical coded signals as humans or animals live. Various glandular secretions operate in a symphonic pattern being conduced by the brain to accomplish the mission assigned, all aimed at maintaining the best body homeostasis. There is adequate but variable space between the signals produced by the neurons located both in the brain and the peripheral nervous system to allow synchronization of secretion production into smooth hormonal or chemical applications by the endocrine and exocrine glands. Summary of the Invention The invention provides a method for controlling endocrine and exocrine glands. Stored neuro-electrical coded signals that are generated and carried in the body are selected from a storage area. The selected waveforms are then transmitted to a treatment member which is in direct contact with the body. The treatment member then broadcasts the selected neuro-electrical coded signals to a muscle in the body. The neuro-electrical coded signals may be selected from a storage area in a computer, such as a scientific computer. The process of transmitting the selected neuro-electrical coded signals can either be done remotely or with the treatment member connected to a control module. The transmission may be seismic, electronic, or via any other suitable method. The invention fiirther provides an apparatus for controlling endocrine and exocrine glands. The apparatus includes a source of collected neuro-electrical coded signals that are indicative of endocrine and exocrine glands ft ctioning, a treatment member in direct contact with the body, means for transmitting collected waveforms to the treatment member, and means for broadcasting the collected neuro-electrical coded signals from the treatment member to the endocrine and exocrine glands. The transmitting means may include a digital to analog converter. The source of collected waveforms preferably comprises a computer which has the collected waveforms stored in digital format. The computer may include separate storage areas for collected neuro-electrical coded signals of different categories. The treatment member may be comprised of an antenna or an electrode, or any other means of broadcasting one or more neuro-electrical coded signals directly to the body. Brief Description of the Drawings The invention is described in greater detail in the following description of examples embodying the best mode of the invention, taken in conjunction with the drawing figures, in which: FIG. 1 is a schematic diagram of one form of apparatus for practicing the method according to the invention; FIG 2 is a schematic diagram of another form of apparatus for practicing the method according to the invention; and , FIG. 3 is a flow chart of the method according to the invention. Descriptions of Examples Embodying the Best Mode of the Invention For the purpose of promoting an understanding of the principles of the invention, references will be made to the embodiments illustrated in the drawings. It will, nevertheless, be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the illustrated device, and such further applications of the principles of the invention illustrated herein being contemplated as would normally occur to the one skilled in the art to which the invention relates. Skin usually has a 1000 to 30,000 ohm resistance while the interior of the body is quite conductive. All coded signals operate at less than 1 volt, naturally. Applied voltage may be up to 20 volts according to the invention to allow for voltage loss during the transmission or conduction of the required coded signals through mylin nerve sheath or resistive fat and other material. Current should always be less than 2 amps output for the invention. Direct conduction into the nerves via electrodes connected directly to such nerves will likely have outputs of less than 3 volts and current of less than one-tenth of an amp. Up to 10 or more channels may be used simultaneously to exert medical treatment on glandular control to aid a patient in moving or performing muscular tasks suitable to his or her well-being as medical treatment. The invention encompasses both a device and a method for endocrine and exocrine gland control by means of neuro-electrical coded signals. One form of a device 10 for endocrine and exocrine gland control, as shown in Fig. 1, is comprised of at least one treatment member 12, and a control module 14. The treatment member 12 is in direct contact with a body and receives a neuro-electrical coded signal from the control module 14. The treatment member 12 may be an electrode, antenna, a seismic transducer, or any other suitable form of conduction attachment for broadcasting endocrine and exocrine gland signals that regulate or operate glandular function in human or animals. The treatment member 12 may be attached to efferent nerves leading to the endocrine and exocrine glands, afferent nerves leading to the brain or brainstem to accomplish modulation of glandular output, the cervical spine, the neck, or the endocrine and exocrine glands in a surgical process. Such surgery may be accomplished with "key-hole" entrance in a thoracic or limb stereo-scope procedure. If necessary a more expansive thoracotomy approach may be required for more proper placement of the treatment member 12. Neuro-electrical coded signals known to modulate endocrine and exocrine gland function may then be sent into nerves that are in close proximity with the brain stem or other parts of the brain. The control module 14 is comprised of at least one control 16, and an antenna 18. The control 16 allows the device to regulate the signal transmission into the body. As shown in Fig. 1, the control module 14 and treatment member 12 can be entirely separate elements allowing the device 10 to be operated remotely. The control module 14 can be unique, or can be any appropriate conventional device which can provide neuro-electrical coded signals for transmission to the treatment member 12. In an alternate embodiment of the device 10, as shown in Fig. 2, the control module 14' and treatment member 12' are connected. Similar members retain the same reference numerals in this figure. Additionally, Fig. 2 further shows another embodiment of the device 10' as being connected to a computer 20, which provides greater capacity to store the neuro-electrical coded signals. The output voltage and amperage provided by the device 10' during treatment shall not exceed 20 volts or 2 amps for each signal. The computer 20 is used to store the unique neuro-electrical coded signals, which are complex and unique to the endocrine and exocrine glands. It is a neuro-electrical coded signal(s) selected from the stored library of neuro-electrical coded signals (waveforms) in the computer 20 which is transmitted to the control module 14' and used for treatment of a patient. The waveform signals, and their creation, are described in greater detail in U.S. Patent Application Serial No. 10/000,005, filed November 20, 2001, and entitled "Device and Method to Record, Store, and Broadcast Specific Brain Waveforms to Modulate Body Organ Functioning," the disclosure of which is incorporated herein by reference. The invention further includes a method, as shown in Fig. 3 , for using the device 10, 10 ' for endocrine and exocrine gland control. The method begins at step 22 by selecting one or more stored neuro-electrical coded signals from a menu of cataloged neuro-electrical coded signals. The neuro-electrical coded signals selected activate, deactivate, secrete, or adjust the endocrine and exocrine glands. Such neuro-electrical coded signals are similar to those naturally produced by the brain structures for balancing and controlling glandular processes. Once selected, the neuro-electrical coded signals may be adjusted, in step 24, to perform a particular function in the body. Alternatively, if it is decided that the neuro-electrical coded signals do not need to be adjusted, step 24 is skipped and the process proceeds directly with step 26. At step 26, the neuro-electrical coded -signal is transmitted to the treatment member 12, 12' ofthe device 10, 10'. Upon receipt of the neuro-electrical coded signals, the treatment member 12, 12' broadcasts the neuro-electrical coded signals to the endocrine and exocrine glands or nerve location, as shown in step 28. The device 10, 10' utilizes appropriate neuro-electrical coded signals to adjust or modulate glandular action via conduction or broadcast of neuro-electrical coded signals into selected nerves. Controlling endocrine and exocrine gland function may require sending neuro-electrical coded signals into one or more nerves, including up to ten nerves simultaneously. It is believed that target glands can only "respond" to their own individual neuro-electrical coded signal. In one embodiment of the invention, the process of broadcasting by the treatment member 12, 12' is accomplished by direct conduction or transmission through unbroken skin in a selected appropriate zone on the neck, head, limb(s), spine, or thorax, or abdomen. Such zone will approximate a position close to the nerve or nerve plexus onto which the signal is to be imposed. The treatment member 12, 12' is brought into contact with the skin in a selected target area that allows for the transport of the signal to the target nerve(s). In an alternate embodiment of the invention, the process of broadcasting the neuro-electrical coded signal is accomplished by direct conduction via attachment of an electrode to the receiving nerve or nerve plexus. This requires a surgical intervention as required to physically attach the electrode to the selected target nerve. Direct implantation on the nervous system of the selected endocrine and exocrine glands may be performed in order to transmit signals to control all or some glandular function. Such implantation can be presynaptic or post synaptic and may be attached to ganglion or nerve plexus associated with the desired secretion function. In yet another embodiment of the invention, the process of broadcasting is accomplished by transposing the neuro-electrical coded signal into a seismic form where it is sent into a region of the head, neck, limb(s), spine, or thorax in a manner that allows the appropriate "nerve" to receive and to obey the coded instructions of such seismic signal. The treatment member 12, 12' is pressed against the unbroken skin surface using an electrode conductive gel or paste medium to aid conductivity. Various features of the invention have been particularly shown and described in connection with the illustrated embodiments of the invention. However, it must be understood that these particular products, and their method of manufacture, do not limit but merely illustrate, and that the invention is to be given its fullest interpretation within the terms of the appended claims.

Claims

We claim: 1. A method for controlling endocrine and exocrine glands comprising the steps of: a. selectmg from a storage area one or more waveforms generated in the body and carried by neurons in the body; b. transmitting or conducting the selected waveforms to a treatment member in contact with the body; and c. broadcasting the selected waveforms from the treatment member to an area in the body is affected to control endocrine and exocrine glands.
2. The method according to claim 1, in which step "a" further includes selecting said waveforms from a storage area in a computer.
3. The method according to claim 1, in which step "b" further comprises transmitting the selected waveforms remotely to the treatment member.
4. The method according to claim 1, in which step "b" ftirther comprises seismic transmission of the selected waveforms.
5. An apparatus for controlling endocrine and exocrine glands, comprising: a. a source of collected waveforms generated in the body and indicative of endocrine and exocrine gland functioning; b. a treatment member adapted to be in direct contact with the body; c. means for transmitting one or more of the collected waveforms to the treatment member; and d. means for broadcasting the collected waveforms from the treatment member to an area in the body such that endocrine and exocrine glands are affected, thereby controlling endocrine and exocrine glands.
6. The apparatus according to claim 5, in which said fr-insmitting means includes a digital to analog converter.
7. The apparatus according to claim 5, in which said source comprises a computer having collected waveforms stored in digital format.
8. The apparatus according to claim 7, in which said computer includes separate storage areas for collecting waveforms of different endocrine and exocrine gland functional categories.
9. The apparatus according to claim 5, in which the treatment member comprises an antenna for broadcasting endocrine and exocrine gland signals.
10. The apparatus according to claim 5, in which the treatment member comprises an electrode.
11. A method for controlling endocrine glands comprising the steps of: a. selecting from a storage area one or more waveforms generated in the body and carried by neurons in the body; b. transmitting or conducting the selected waveforms to a treatment member in contact with the body; and c. broadcasting the selected waveforms from the treatment member to an area in the body is affected to control endocrine glands.
12. The method according to claim 11, in which step "a" further includes selecting said waveforms from a storage area in a computer.
13. The method according to claim 11, in which step "b" further comprises transmitting the selected waveforms remotely to the treatment member.
14. The method according to claim 11, in which step "b" further comprises seismic transmission of the selected waveforms.
15. An apparatus for controlling endocrine glands, comprising: a. a source of collected waveforms generated in the body and indicative of endocrine gland functioning; b. a treatment member adapted to be in direct contact with the body; c. means for transmitting one or more of the collected waveforms to the treatment member; and d. means for broadcasting the collected waveforms from the treatment member to an area in the body such that endocrine and exocrine glands are affected, thereby controlling endocrine glands.
16. The apparatus according to claim 15, in which said transmitting means includes a digital to analog converter.
17. The apparatus according to claim 15, in which said source comprises a computer having collected waveforms stored in digital format.
18. The apparatus according to claim 17, in which said computer includes separate storage areas for collecting waveforms of different endocrine gland functional categories.
19. The apparatus according to claim 15, in which the treatment member comprises an antenna for broadcasting endocrine gland signals.
20. The apparatus according to claim 15, in which the treatment member comprises an electrode.
21. A method for controlling exocrine glands comprising the steps of: a. selecting from a storage area one or more waveforms generated in the body and carried by neurons in the body; b. transmitting or conducting the selected waveforms to a treatment member in contact with the body; and c. broadcasting the selected waveforms from the treatment member to an area in the body is affected to control exocrine glands.
22. The method according to claim 21, in which step "a" further includes selecting said waveforms from a storage area in a computer.
23. The method according to claim 21, in which step "b" further comprises transmitting the selected waveforms remotely to the treatment member.
24. The method according to claim 21, in which step "b" further comprises seismic transmission of the selected waveforms.
25. An apparatus for controlling exocrine glands, comprising: a. a source of collected waveforms generated in the body and indicative of exocrine gland functioning; b. a treatment member adapted to be in direct contact with the body; c. means for transmitting one or more of the collected waveforms to the treatment member; and d. means for broadcasting the collected waveforms from the treatment member to an area in the body such that endocrine and exocrine glands are affected, thereby controlling exocrine glands.
26. The apparatus according to claim 25, in which said transmitting means includes a digital to analog converter.
27. The apparatus according to claim 25, in which said source comprises a computer having collected waveforms stored in digital format.
28. The apparatus according to claim 27, in which said computer includes separate storage areas for collecting waveforms of different exocrine gland functional categories.
29. The apparatus according to claim 25, in which the treatment member comprises an antenna for broadcasting exocrine gland signals.
30. The apparatus according to claim 25, in which the treatment member comprises an electrode.
PCT/US2004/022120 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals Ceased WO2005007234A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MXPA06000239A MXPA06000239A (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals.
AU2004257711A AU2004257711A1 (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
EP04777910A EP1651307A2 (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
JP2006518940A JP2007528751A (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by neuroelectrically encoded signals
CA002531679A CA2531679A1 (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48608903P 2003-07-10 2003-07-10
US60/486,089 2003-07-10

Publications (2)

Publication Number Publication Date
WO2005007234A2 true WO2005007234A2 (en) 2005-01-27
WO2005007234A3 WO2005007234A3 (en) 2005-09-15

Family

ID=34079190

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/022120 Ceased WO2005007234A2 (en) 2003-07-10 2004-07-12 Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals

Country Status (7)

Country Link
US (1) US7058446B2 (en)
EP (1) EP1651307A2 (en)
JP (1) JP2007528751A (en)
AU (1) AU2004257711A1 (en)
CA (1) CA2531679A1 (en)
MX (1) MXPA06000239A (en)
WO (1) WO2005007234A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265956B2 (en) 2013-03-08 2016-02-23 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9440065B2 (en) 2013-04-19 2016-09-13 Oculeve, Inc. Nasal stimulation devices and methods
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US9764150B2 (en) 2014-10-22 2017-09-19 Oculeve, Inc. Contact lens for increasing tear production
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation
US10722718B2 (en) 2010-11-16 2020-07-28 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7640052B2 (en) 2004-05-28 2009-12-29 Ippp, Llc Method of integrated proton beam and therapeutic magnetic resonance therapy
US7801585B1 (en) 2003-06-02 2010-09-21 Newlife Sciences Llc System for analyzing and treating abnormality of human and animal tissues
US7725176B2 (en) * 2003-07-10 2010-05-25 Schuler Eleanor L Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
US9254388B2 (en) * 2003-07-10 2016-02-09 Codes Of Life, Llc Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
US7346382B2 (en) 2004-07-07 2008-03-18 The Cleveland Clinic Foundation Brain stimulation models, systems, devices, and methods
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
AU2006222983B2 (en) * 2005-03-15 2012-08-16 The Regents Of The University Of California Method and system for modulating energy expenditure and neurotrophic factors
US9339650B2 (en) 2005-04-13 2016-05-17 The Cleveland Clinic Foundation Systems and methods for neuromodulation using pre-recorded waveforms
US8112154B2 (en) * 2005-04-13 2012-02-07 The Cleveland Clinic Foundation Systems and methods for neuromodulation using pre-recorded waveforms
US9211408B2 (en) 2005-04-13 2015-12-15 The Cleveland Clinic Foundation System and method for neuromodulation using composite patterns of stimulation or waveforms
US20090149732A1 (en) * 2007-12-08 2009-06-11 Weinstock Ronald J System for use of electrical resonant frequencies in analyzing and treating abnormality of human and animal tissues
US9220889B2 (en) 2008-02-11 2015-12-29 Intelect Medical, Inc. Directional electrode devices with locating features
US8019440B2 (en) 2008-02-12 2011-09-13 Intelect Medical, Inc. Directional lead assembly
US9310985B2 (en) 2008-05-15 2016-04-12 Boston Scientific Neuromodulation Corporation System and method for determining target stimulation volumes
US9272153B2 (en) 2008-05-15 2016-03-01 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
US20100324627A1 (en) * 2008-07-28 2010-12-23 Newlife Sciences, Llc Method and apparatus for resistivity measurement, detection and treatment in living tissue
CA2772330A1 (en) 2009-08-27 2011-03-03 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
WO2011068997A1 (en) 2009-12-02 2011-06-09 The Cleveland Clinic Foundation Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming
WO2011159688A2 (en) 2010-06-14 2011-12-22 Boston Scientific Neuromodulation Corporation Programming interface for spinal cord neuromodulation
CA2819461A1 (en) 2010-11-30 2012-06-07 Newlife Sciences Llc Apparatus and method for treatment of pain with body impedance analyzer
US9592389B2 (en) 2011-05-27 2017-03-14 Boston Scientific Neuromodulation Corporation Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information
WO2013023081A1 (en) 2011-08-09 2013-02-14 Boston Scientific Neuromodulation Corporation Remote control for blind clinical trials of electrical stimulation
AU2012325893B2 (en) 2011-10-19 2015-04-16 Sympara Medical Inc. Methods and devices for treating hypertension
EP2879757B1 (en) 2012-08-04 2019-06-26 Boston Scientific Neuromodulation Corporation Systems and methods for storing and transferring registration, atlas, and lead information between medical devices
EP2890454B1 (en) 2012-08-28 2017-11-08 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
US9792412B2 (en) 2012-11-01 2017-10-17 Boston Scientific Neuromodulation Corporation Systems and methods for VOA model generation and use
US9959388B2 (en) 2014-07-24 2018-05-01 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for providing electrical stimulation therapy feedback
US10265528B2 (en) 2014-07-30 2019-04-23 Boston Scientific Neuromodulation Corporation Systems and methods for electrical stimulation-related patient population volume analysis and use
US10272247B2 (en) 2014-07-30 2019-04-30 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
US9974959B2 (en) 2014-10-07 2018-05-22 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
AU2016268259B2 (en) 2015-05-26 2019-01-31 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
US10780283B2 (en) 2015-05-26 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
US20160375248A1 (en) 2015-06-29 2016-12-29 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects
ES2940303T3 (en) 2015-06-29 2023-05-05 Boston Scient Neuromodulation Corp Stimulation parameter selection systems by use of targets and direction
US11154238B2 (en) 2015-08-07 2021-10-26 Electroceuticals, Llc Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals
US10071249B2 (en) 2015-10-09 2018-09-11 Boston Scientific Neuromodulation Corporation System and methods for clinical effects mapping for directional stimulation leads
US10716942B2 (en) 2016-04-25 2020-07-21 Boston Scientific Neuromodulation Corporation System and methods for directional steering of electrical stimulation
JP6905541B2 (en) 2016-06-24 2021-07-21 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Systems and methods for visual analysis of clinical effects
US10350404B2 (en) 2016-09-02 2019-07-16 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and directing stimulation of neural elements
US10780282B2 (en) 2016-09-20 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
JP6828149B2 (en) 2016-10-14 2021-02-10 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Systems and methods for closed-loop determination of stimulation parameter settings for electrical stimulation systems
AU2017391436B2 (en) 2017-01-03 2020-06-18 Boston Scientific Neuromodulation Corporation Systems and methods for selecting MRI-compatible stimulation parameters
WO2018132334A1 (en) 2017-01-10 2018-07-19 Boston Scientific Neuromodulation Corporation Systems and methods for creating stimulation programs based on user-defined areas or volumes
US10625082B2 (en) 2017-03-15 2020-04-21 Boston Scientific Neuromodulation Corporation Visualization of deep brain stimulation efficacy
US11357986B2 (en) 2017-04-03 2022-06-14 Boston Scientific Neuromodulation Corporation Systems and methods for estimating a volume of activation using a compressed database of threshold values
EP3651849B1 (en) 2017-07-14 2023-05-31 Boston Scientific Neuromodulation Corporation Estimating clinical effects of electrical stimulation
US10960214B2 (en) 2017-08-15 2021-03-30 Boston Scientific Neuromodulation Corporation Systems and methods for controlling electrical stimulation using multiple stimulation fields
US11285329B2 (en) 2018-04-27 2022-03-29 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and programming electrical stimulation
WO2019210202A1 (en) 2018-04-27 2019-10-31 Boston Scientific Neuromodulation Corporation Multi-mode electrical stimulation systems and methods of making and using
KR102930695B1 (en) 2019-06-12 2026-02-24 트루릴리프 엘엘씨 Systems and methods for delivering pulsed current to biological tissue
US11911605B2 (en) 2021-03-05 2024-02-27 Truerelief Llc Method and apparatus for injury treatment
EP4291294A1 (en) 2021-04-27 2023-12-20 Boston Scientific Neuromodulation Corporation Systems and methods for automated programming of electrical stimulation
US12403313B2 (en) 2021-06-15 2025-09-02 Boston Scientific Neuromodulation Corporation Methods and systems for estimating neural activation by stimulation using a stimulation system
CN118251257A (en) 2021-12-09 2024-06-25 波士顿科学神经调制公司 Methods and systems for monitoring or assessing movement disorders or other physiological parameters using a stimulation system
US12471831B2 (en) 2021-12-10 2025-11-18 Boston Scientific Neuromodulation Corporation Systems and methods for generating and using response maps for electrical stimulation
US12690801B2 (en) 2021-12-10 2026-07-28 Boston Scientific Neuromodulation Corporation Methods and systems for determining and using an intensity index for electrical stimulation
WO2023167872A1 (en) 2022-03-02 2023-09-07 Boston Scientific Neuromodulation Corporation Systems and methods for monitoring stimulation drift in an electrical stimulation system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US6171239B1 (en) * 1998-08-17 2001-01-09 Emory University Systems, methods, and devices for controlling external devices by signals derived directly from the nervous system
US6853862B1 (en) * 1999-12-03 2005-02-08 Medtronic, Inc. Gastroelectric stimulation for influencing pancreatic secretions
US6885888B2 (en) * 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
AU6419701A (en) * 2000-05-31 2001-12-11 Impulse Dynamics N.V. Electropancreatography
US6681136B2 (en) * 2000-12-04 2004-01-20 Science Medicus, Inc. Device and method to modulate blood pressure by electrical waveforms
US6775573B2 (en) * 2001-03-01 2004-08-10 Science Medicus Inc. Electrical method to control autonomic nerve stimulation of gastrointestinal tract
US7155285B2 (en) * 2002-12-17 2006-12-26 Xiaoming Wang Apparatus for inducing energies of alpha rhythm to the human body

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722718B2 (en) 2010-11-16 2020-07-28 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US11771908B2 (en) 2010-11-16 2023-10-03 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US10328262B2 (en) 2010-11-16 2019-06-25 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10835748B2 (en) 2010-11-16 2020-11-17 Oculeve, Inc. Stimulation devices and methods
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US9265956B2 (en) 2013-03-08 2016-02-23 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
US10537469B2 (en) 2013-03-12 2020-01-21 Oculeve, Inc. Implant delivery devices, systems, and methods
US10835738B2 (en) 2013-04-19 2020-11-17 Oculeve, Inc. Nasal stimulation devices and methods
US9737702B2 (en) 2013-04-19 2017-08-22 Oculeve, Inc. Nasal stimulation devices and methods
US10967173B2 (en) 2013-04-19 2021-04-06 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
US10799695B2 (en) 2013-04-19 2020-10-13 Oculeve, Inc. Nasal stimulation devices and methods
US10155108B2 (en) 2013-04-19 2018-12-18 Oculeve, Inc. Nasal stimulation devices and methods
US9440065B2 (en) 2013-04-19 2016-09-13 Oculeve, Inc. Nasal stimulation devices and methods
US10238861B2 (en) 2013-04-19 2019-03-26 Oculeve, Inc. Nasal stimulation devices and methods for treating dry eye
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US9956397B2 (en) 2014-02-25 2018-05-01 Oculeve, Inc. Polymer Formulations for nasolacrimal stimulation
US10799696B2 (en) 2014-02-25 2020-10-13 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10722713B2 (en) 2014-07-25 2020-07-28 Oculeve, Inc. Stimulation patterns for treating dry eye
US9687652B2 (en) 2014-07-25 2017-06-27 Oculeve, Inc. Stimulation patterns for treating dry eye
US10610695B2 (en) 2014-10-22 2020-04-07 Oculeve, Inc. Implantable device for increasing tear production
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US10780273B2 (en) 2014-10-22 2020-09-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10112048B2 (en) 2014-10-22 2018-10-30 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US9764150B2 (en) 2014-10-22 2017-09-19 Oculeve, Inc. Contact lens for increasing tear production
US9737712B2 (en) 2014-10-22 2017-08-22 Oculeve, Inc. Stimulation devices and methods for treating dry eye
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10940310B2 (en) 2016-02-19 2021-03-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10610095B2 (en) 2016-12-02 2020-04-07 Oculeve, Inc. Apparatus and method for dry eye forecast and treatment recommendation

Also Published As

Publication number Publication date
WO2005007234A3 (en) 2005-09-15
US20050010250A1 (en) 2005-01-13
US7058446B2 (en) 2006-06-06
CA2531679A1 (en) 2005-01-27
EP1651307A2 (en) 2006-05-03
MXPA06000239A (en) 2006-04-07
AU2004257711A1 (en) 2005-01-27
JP2007528751A (en) 2007-10-18

Similar Documents

Publication Publication Date Title
US7058446B2 (en) Regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
US8818502B2 (en) Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
US20050021090A1 (en) Method and device for regulation of limbic system of the brain by means of neuro-electrical coded signals
US6775573B2 (en) Electrical method to control autonomic nerve stimulation of gastrointestinal tract
US8812096B2 (en) Biological interface system with patient training apparatus
US6633779B1 (en) Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
JP2008543357A (en) Method and system for regulating body organ function
Prochazka Neurophysiology and neural engineering: a review
DiMarco et al. Inspiratory muscle pacing in spinal cord injury: case report and clinical commentary
CN109011141B (en) Single-phase and double-phase constant-current electrical stimulator for rat brain
US10010713B2 (en) Nerve stimulation device for treating or reducing paralysis
US20180296832A1 (en) Nerve stimulation device for treating or reducing paralysis
US9254388B2 (en) Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
Askari et al. Closed loop Microfabricated facial reanimation device coupling EMG-Driven facial nerve stimulation with a chronically implanted multichannel cuff electrode
Mushahwar et al. Could cortical signals control intraspinal stimulators? A theoretical evaluation
Hambrecht et al. The future possibilities for neural control
Delgado et al. Two-way transdermal communication with the brain.
US11957469B2 (en) Modified nerve cuff electrode design for stable recording and/or stimulation
장정우 Development of Wireless Neural Microsystem for Bidirectional Brain Machine Interface
Zhang et al. A Wireless Self-Fine-Tuning Artificial Neural Pathway Implant for Near-Real-Time Close-Loop Motor Modulation
CA2529866A1 (en) Skeletal muscle control by means of neuro-electrical signals
Li Activities of cortical motor neurons trigger electrical stimulation of lower motor neurons in the spinal cord
Hassell A wireless closed-loop implantable system for the real-time surveillance and modulation of central nervous system recovery following spinal cord injury
Charles Advances in neural and electromyographic recording techniques and applications to powered prostheses
MXPA06002998A (en) Device and method for conducting or broadcast actual neuro electrical coded signals for medical treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004257711

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2531679

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/000239

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2006518940

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2004257711

Country of ref document: AU

Date of ref document: 20040712

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004257711

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004777910

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004777910

Country of ref document: EP